scholarly journals Emphysematous cystitis in an elderly Japanese patient with type 2 diabetes mellitus

2019 ◽  
Vol 7 (3) ◽  
pp. 585-586 ◽  
Author(s):  
Hironori Yashima ◽  
Michishige Terasaki ◽  
Hideki Kushima ◽  
Tsutomu Hirano
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Japanese Patient ◽  
Emphysematous Cystitis ◽  
Elderly Japanese

scholarly journals Cigarette Smoking and Risk of Type 2 Diabetes Mellitus among Middle-aged and Elderly Japanese Men and Women

2004 ◽  
Vol 160 (2) ◽  
pp. 158-162 ◽  
Author(s):  
T. Sairenchi ◽  
H. Iso ◽  
A. Nishimura ◽  
T. Hosoda ◽  
F. Irie ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Cigarette Smoking ◽  
Middle Aged ◽  
Japanese Men ◽  
Men And Women ◽  
Elderly Japanese

scholarly journals Emphysematous cystitis in a patient with type-2 diabetes mellitus

2011 ◽  
Vol 15 (5) ◽  
pp. 55
Author(s):  
Anil Bhansali ◽  
YashpalVikas Gogate ◽  
Rama Walia ◽  
Prathosh Gangadhar
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Emphysematous Cystitis

scholarly journals The effects of 12-month administration of tofogliflozin on electrolytes and dehydration in mainly elderly Japanese patients with type 2 diabetes mellitus

2018 ◽  
Vol 46 (12) ◽  
pp. 5117-5126 ◽  
Author(s):  
Toshihiro Higashikawa ◽  
Tomohiko Ito ◽  
Takurou Mizuno ◽  
Keiichirou Ishigami ◽  
Masaru Kohori ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Japanese Patients ◽  
Glycated Haemoglobin ◽  
Creatinine Ratio ◽  
Sodium Potassium ◽  
Elderly Japanese ◽  
Elderly Japanese Patients

Objective To assess the effect of 12 months of treatment with tofogliflozin on electrolytes and dehydration in Japanese patients with type 2 diabetes mellitus (T2DM) Methods This retrospective study involved mainly elderly patients with T2DM who had received tofogliflozin for 12 months. Data on glycated haemoglobin (HbA1c), serum electrolytes (sodium, potassium, chloride), haematocrit, estimated glomerular filtration rate (eGFR) and blood urea nitrogen (BUN)/creatinine ratio were retrieved and analysed. Results Data from 69 patients (77% of whom were ≥65 years) showed that there was a significant reduction in HbA1c over the 12-month treatment period with tofogliflozin. However, the drug had no significant effect on levels of haematocrit, electrolytes, eGFR or BUN/creatinine ratio. Conclusion This retrospective analysis of data from mainly elderly Japanese patients with T2DM showed that 12-month administration of tofogliflozin exhibited glucose-lowering capabilities with accompanying low risk of electrolyte abnormalities and dehydration.

Sign in / Sign up

Export Citation Format

Share Document